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Abscess, lung, diagnosis of Candida abscesses by
F-18-ﬂuorodeoxyglucose PET (research note), 493
Acinetobacter spp.
b-lactam activity against, 24
clinical impact and pathogenicity (review), 868
faecal carriage in community (research note), 329
Acinetobacter baumannii
b-lactam activity against, 24
colistin treatment of ICU-acquired infections, 115
combined colistin and rifampicin therapy for
carbapenem-resistant infections (correspondence),
682
faecal carriage in community (research note), 329
hospital outbreak of multi-resistant strain, risk factors and
prognosis, 540
imipenem-resistant, risk factors for acquisition, 874
OXA-51 novel class D carbapenemase in, 15
pneumonia, efﬁcacy of imipenem alone or with amikacin,
319
sequences of seven OXA-type class D
b-lactamases from carbapenem-resistant isolates
(research note), 326
Adenovirus E1A gene, effect on nitric oxide production in
alveolar epithelial cells, 644
Aeromonas hydrophila, pathogenicity, 553
Alanine aminotransferase (ALT), serum levels in
Mycoplasma pneumoniae pneumonia, 507 (research
note), 1051 (correspondence)
Albicans ID2 agar (research note), 245, 513 (corrigendum)
Allergy, effect of probiotics (review), 958
Alveolar epithelial cells, effect of adenovirus E1A gene on
nitric oxide production, 644
Amikacin, in combination with imipenem, Acinetobacter
baumannii pneumonia, 319
Amikacin-resistant Escherichia coli, aac genes and (research
note), 71
Amoxycillin, susceptibility of Helicobacter pylori, 307
Amoxycillin—clavulanate, Escherichia coli susceptibility to
(research note), 237
Amphotericin B
Candida susceptibility testing, 486
high loading doses of liposomal amphotericin B in
experimental invasive aspergillosis, 999
Ampliﬁed fragment length polymorphism analysis,
ﬂuorescent, Legionella pneumophila genotyping, 704
Anaerobes
bacteraemia in cancer patients, 724
Gram-negative, antimicrobial susceptibilities, 820
Antibiotic Resistance; Prevention and Control (ARPAC),
report of consensus conference, 938
Antibiotic-associated diarrhoea, role of Candida (editorial),
1
Antibiotics
b-lactam
activity against Actinobacter spp., 24
carbapenem activity in pneumonia caused by
porin-deﬁcient Klebsiella pneumoniae producing
FOX-5 b-lactamase, 31
pharmacodynamics of continuous infusion
b-lactams for ICU pulmonary infections (research
note), 418
use of HPLC to monitor plasma concentrations during
endocarditis treatment (research note), 76
see also names of speciﬁc drugs
irrigation with antibiotic-containing solutions (review),
862
sepsis management, time-to-positivity assay in, 109
use
effect of policy to restrict use on resistance rates in
Streptococcus pneumoniae (research note), 925
predicted effect of guidelines for community-acquired
pneumonia, 992
see also names of speciﬁc drugs
Antimicrobial resistance
co-trimoxazole, integrons and gene cassettes in clinical
isolates of Gram-negative bacteria, 185
erythromycin and clindamycin resistance in Streptococcus
agalactiae (research note), 579
erythromycin resistance in group A streptococci (research
note), 335
Escherichia coli from community-acquired urinary tract
infections, 199
ﬂuoroquinolone-resistant Gram-negative bacteria from
bacteraemic children with cancer (research note),
505
haemodialysis and, 547
Helicobacter pylori, 307
inducible clindamycin resistance in staphylococci
(research note), 582
linezolid resistance in Germany 2001-2002, 39
macrolide resistance mechanisms in Streptococcus
pneumoniae, 312, 332 (research note)
mechanisms of resistance in Shigella spp. causing
traveller’s diarrhoea (research note), 1044
and mortality of nosocomial bacterial infections (research
note), 502
Mycobacterium tuberculosis, pyrosequencing for, 122
pan-drug-resistance
Pseudomonas aeruginosa causing nosocomial infection
(research note), 670
use of term in Gram-negative bacteria (correspondence),
1049
Propionibacterium acnes, 204
Pseudomonas aeruginosa
intensive care units, 887
pan-drug-resistance (research note), 670
report of Antibiotic Resistance; Prevention and Control
Consensus Conference, 938
Staphylococcus aureus, Nepal (research note), 235
Stenotrophomonas maltophilia, 880
Streptococcus pneumoniae
effect of policy to restrict antibiotic usage, Taiwan
(research note), 925
macrolide resistance mechanisms, 312, 332 (research
note)
surveillance studies (correspondence), 422
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therapeutic options for resistant nosocomial infections
(research note), 778
Antimicrobial susceptibility testing
b-lactam activity against Acinetobacter spp., 24
bacteria containing qnr gene and FOX-5
b-lactamase (research note), 402
Candida spp., correlation between EUCAST procedure
and four commercial techniques, 486
coagulase-negative staphylococci isolated from blood
cultures, effect of discontinuing routine testing
(research note), 1037
doripenem, 974
Escherichia coli, amoxycillin—clavulanate combinations
(research note), 237
Gram-negative anaerobes, 820
Helicobacter pylori, 307
Mycobacterium tuberculosis
comparison of BACTEC TB-460 and ﬂow cytometric
assay, 372
pyrosequencing, 122
Propionibacterium acnes, 204
staphylococci, evaluation of Vitek 2 system (research
note), 150
Antiretroviral therapy, highly active see HAART
Antiviral agents, disruption of DNA polymerases as target
for antiherpesvirus drugs (review), 437
Aspergillus infections
after lung transplant, 359
in chronic obstructive pulmonary disease (editorial), 427
high loading doses of liposomal amphotericin B in
experimental invasive aspergillosis, 999
Audiometry, investigation of hearing loss in brucellosis,
559
BacT/Alert, isolation of staphylococci in paediatric
intensive care unit (research note), 1035
Bacteraemia
anaerobic, cancer patients, 724
children with non-typhi Salmonella gastroenteritis, 651
effect of discontinuing routine antimicrobial sensitivity
testing of coagulase-negative staphylococci isolated
from blood cultures (research note), 1037
Pseudomonas aeruginosa, community-acquired (research
note), 415
staphylococcal, blood culture procedures for isolation of
staphylococci in paediatric intensive care unit
(research note), 1035
Streptococcus bovis, 814
Streptococcus pneumoniae, 919
Bacteroides spp.
antimicrobial susceptibility, 820
bacteraemia in cancer patients, 724
Bartonellosis (editorial), 167
BD Phoenix, susceptibility testing of ﬂuoroquinolones and
b-lactams (research note), 402
Beeswax, honey and olive oil in treatment of diaper
dermatitis (research note), 160
Beta-lactamase inhibitors, activity against Actinobacter spp.,
24
Beta-lactamases
class D beta-lactamases from carbapenem-resistant
Acinetobacter baumannii (research note), 326
OXA-51, 15
DHA-1 ampC beta-lactamase in Proteus mirabilis (research
note), 591
DHA-3 in Klebsiella pneumoniae, 893
extended-spectrum
Enterobacteriaceae (research note), 588
frequency of production by Escherichia coli and Klebsiella
pneumoniae, 625
Proteus mirabilis, 395
FOX-5, antimicrobial susceptibility testing of bacteria
containing (research note), 402
metallo-b-lactamases produced by carbapenem-resistant
Pseudomonas aeruginosa, 73 (research note), 937
(correspondence)
PER-1- and OXA-10-like, ceftazidime-resistant
Pseudomonas aeruginosa from intensive care patients,
193
Beta-lactams see Antibiotics, b-lactam
BiGGY agar (research note), 245, 513 (corrigendum)
Biochips, Mycobacterium tuberculosis analysis, 531
Bioﬁlm formation, genetics of (review), 967
Bone, human immunoglobulin scintigraphy in brucellosis
patients, 480, 686 (corrigendum)
Bordetella pertussis infection, association with prolonged
coughing in children, 801
Borrelia burgdorferi, ELISA analysis of IgG antibodies
(research note), 147
Bowel surgery see Colon
Brevibacterium casei, pericardial infection (correspondence),
164
Brucellosis
correlation between animal and human brucellosis in
Italy, 632
diagnosis
real-time LightCycler PCR assay, 713
rose Bengal test, 221
hearing loss, investigation by audiometry, 559
Tc-99m polyclonal human immunoglobulin scintigraphy,
480, 686 (corrigendum)
Burkholderia pseudomallei identiﬁcation in blood culture
supernatants by coagglutination assay (research
note), 930
Burns, interference of Lactobacillus plantarum with
Pseudomonas aeruginosa infections, 472
C-reactive protein as marker of infection in the critically ill,
101
Cadherin: role of E-cadherin in crossing of host barriers by
Listeria monocytogenes (review), 430
Cag pathogenicity island status of Helicobacter pylori
infections, assessment with serology and PCR
(research note), 66
CagA, and Helicobacter pylori pathogenicity (review), 602
Campylobacter spp.
identiﬁcation by real-time PCR, 281
pericarditis and myocarditis (editorial), 253
Campylobacter concisus, phenotypic and genotypic
characteristics, 288
Campylobacter fetus (research note), 341
Campylobacter jejuni, heat-stable serotypes, cytokine
induction in peripheral blood mononuclear cells
(research note), 63
Cancer patients, anaerobic bacteraemia in, 724
Candida spp.
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antibiotic-associated diarrhoea (editorial), 1
endocarditis, caspofungin treatment (correspondence),
248
identiﬁcation
by Raman spectroscopy in peritonitis patients, 353
evaluation of three differential media for presumptive
identiﬁcation (research note), 245, 513
(corrigendum)
lung abscesses, diagnosis by F-18-ﬂuorodeoxyglucose
positron emission tomography (research note), 493
in nosocomial candidaemia in non-neutropenic patients,
908
susceptibility testing, correlation between EUCAST
procedure and four commercial techniques, 486
Candida albicans, diaper dermatitis, topical treatment
with honey, olive oil and beeswax (research
note), 160
Candidaemia, nosocomial, non-neutropenic patients, 908
Candidiasis, vulvovaginal, Flemish patients, 1005
Carbapenemases, carbapenem-resistant Acinetobacter
baumannii (research note), 326
OXA-51, 15
Carbapenems
activity in pneumonia caused by porin-deﬁcient Klebsiella
pneumoniae producing FOX-5
b-lactamase, 31
global surveillance of doripenem, 974
resistance
Acinetobacter baumannii, class D b-lactamases, 15, 326
(research note)
Pseudomonas aeruginosa, metallo-b-lactamase production,
73 (research note), 937 (correspondence)
susceptibility of Gram-negative anaerobes, 820
Case clustering in infective endocarditis, role of availability
bias (editorial), 955
Caspofungin, fungal endocarditis (correspondence), 248
Cat-scratch disease (editorial), 167
Catheter-related infections
diagnosis of Candida lung abscesses by
F-18-ﬂuorodeoxyglucose positron emission
tomography (research note), 493
haemodialysis patients, 547
CD163 serum levels, predictive value in tuberculosis
patients, 730
Cefepime activity in pneumonia caused by porin-deﬁcient
Klebsiella pneumoniae producing FOX-5 b-lactamase,
31
Ceftazidime-resistant Pseudomonas aeruginosa, PER-1- and
OXA-10-like b-lactamsases, intensive care patients,
193
Cephalosporins, prophylactic, orthopaedic and vascular
surgery (editorial), 775
Cervicitis, chlamydial, Poland (correspondence), 683
Chlamydia trachomatis infection
cervicitis in Poland (correspondence), 683
detection, comparison of strand displacement and ligase
chain ampliﬁcation (research note), 761
prevalence in heterosexuals attending STD clinics,
Slovenia (research note), 240
screening, 687 (editorial), 683 (correspondence)
Taiwan, 915
CHROMagar Candida (research note), 245, 513
(corrigendum)
Chronic obstructive pulmonary disease (COPD),
aspergillosis in (editorial), 427
Ciproﬂoxacin
combined with rifampicin, prosthetic joint infections
(research note), 843
resistance
class 1 integrons in ciproﬂoxacin-resistant Escherichia
coli, 898
Gram-negative bacteria from bacteraemic children with
cancer (research note), 505
Clarithromycin resistance, Helicobacter pylori, 307
Clavulanate see Amoxycillin—clavulanate
Clindamycin resistance
inducible resistance in staphylococci (research note), 582
prevalence of inducible resistance in macrolide-resistant
staphylococci (research note), 337
Streptococcus agalactiae (research note), 579
Clostridium spp., bacteraemia in cancer patients, 724
Colistin
combined colistin and rifampicin therapy for
carbapenem-resistant Acinetobacter baumannii
infections (correspondence), 682
ICU-acquired infections caused by multiresistant Gram-
negative bacteria, 115
Colistin methanesulphonate assay, 243 (research note), 773
(correspondence)
Colon, elective open surgery
bacteriology of abdominal wounds (research note), 155
effect on contamination and wound infection of
mechanical bowel preparation with
polyethyleneglycol (research note), 155
COPD see Chronic obstructive pulmonary disease
Corticosteroid therapy and aspergillosis in COPD patients
(editorial), 427
Co-trimoxazole resistance in clinical isolates of Gram-
negative bacteria, integrons and gene cassettes in,
185
Coughing, prolonged, and community-acquired pathogens
in children, 801
Cryptococcosis, AIDS-associated, blood cytokines in, 297
Cryptococcus neoformans, interactions with HIV in AIDS-
associated cryptococcosis, 297
Cystic ﬁbrosis
antimicrobial therapy for pulmonary colonisation by
Pseudomonas aeruginosa (research note), 690
assay method for colistin sulphomethate (research note),
243
Pneumocystis jirovecii colonisation and genotypes, 1012
Cytokines
blood cytokines in AIDS-associated cryptococcosis, 297
possible induction in peripheral blood mononuclear cells
by heat-stable serotypes of Campylobacter jejuni
(research note), 63
Cytomegalovirus infection, renal transplant recipients, 518
comparison of valacyclovir and ganciclovir prophylaxis,
736
Dalbavancin, in-vitro activity against Gram-positive
isolates, 95
Dermatitis, diaper, topical treatment with honey, olive
oil and beeswax (research note), 160
Dialysis, aetiology of peritoneal dialysis-related peritonitis
(research note), 837
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Diaper dermatitis, topical treatment with honey, olive oil
and beeswax (research note), 160
Diarrhoea
antibiotic-associated, Candida and (editorial), 1
effect of probiotics (review), 958
traveller’s, antimicrobial resistance mechanisms in
Shigella spp. (research note), 1044
DNA ampliﬁcation tests, Chlamydia trachomatis infection
(research note), 761
DNA polymerase, herpesvirus, disruption as antiviral
strategy (review), 437
Doripenem, global surveillance of antimicrobial activity,
974
Empyema, irrigation with antibiotic-containing solutions
(review), 862
Encephalitis, tick-borne, immunisation by widely-used
vaccines (correspondence), 424
Endocarditis
b-lactam treatment, HPLC monitoring of plasma
concentrations (research note), 76
case clustering: role of availability bias (editorial), 955
fungal, caspofungin treatment (correspondence), 248
Streptococcus bovis, 814
Enterobacteriaceae, extended-spectrum beta-lactamases
(research note), 588
Enterococci
dalbavancin activity against, 95
linezolid resistance, 39
Enterococcus faecalis, vancomycin-resistant, intensive care
unit in Cyprus (research note), 232
Enterovirus, meningitis, diagnosis by reverse
transcription-PCR, 131
Enterovirus Consensus kit, 131
Entomophthoramycosis, nomenclature of causal agents
(correspondence), 248
Environmental risk factors, hepatitis A in Bosnia and
Herzegovina (research note), 145
Enzyme immunoassays, detection of inﬂuenza virus and
respiratory syncytial virus (research note), 848
Enzyme-linked immunosorbent assay (ELISA)
analysis of Borrelia burgdorferi IgG antibodies (research
note), 147
Focus ELISA test for herpes simplex virus type-2
(correspondence), 423
fourth generation, HIV detection (research note), 850
RT-PCR ELISA for detection of inﬂuenza virus and
respiratory syncytial virus (research note), 848
Epidemiology, mortality of nosocomial bacterial infections
according to antibiotic susceptibility (research
note), 502
Erythromycin resistance
decreasing rates of resistance in Streptococcus pneumoniae,
Taiwan (research note), 925
group A streptococci (research note), 335
Streptococcus agalactiae (research note), 579
Streptococcus pyogenes, mef(A)-containing genetic elements
in (research note), 917
Escherichia coli
antibiotic resistance
aac genes and amikacin resistance (research note), 71
class 1 integrons in ciproﬂoxacin-resistant strains, 898
in community-acquired urinary tract infections, 199
evolution of ﬂuoroquinolone resistance in urinary tract
isolates, 301
bactericidal activity of ﬂuoroquinolones against
plasmid-mediated QnrA-producing Escherichia coli
(correspondence), 1048
extended-spectrum b-lactamase-producing, 625
susceptibility to amoxycillin—clavulanate (research note),
237
verocytotoxigenic serotype O111, transmission form cattle
stable to child (research note), 767
European Working Group for Legionella Infections
(EWGLI) (research note), 413
F-18-ﬂuorodeoxyglucose positron emission tomography,
diagnosis of Candida lung abscesses (research note),
493
Fasciola hepatica infection (editorial), 859
Fever of unknown origin, after neurosurgery, analysis of
serum procalcitonin levels (research note), 679
Fluconazole, Candida susceptibility testing, 486
Fluorescence resonance energy transfer (FRET) PCR,
real-time ﬂuorescence resonance energy transfer,
281
Fluoroquinolones see Quinolones
Fungi
clinical nomenclature of causal agents of
entomophthoramycosis (correspondence), 248
see also speciﬁc fungi/fungal infections
Ganciclovir, cytomegalovirus prophylaxis in renal
transplant recipients, 736
Gastroenteritis, non-typhi Salmonella, and associated
bacteraemia in children, 651
Gastrointestinal health, effect of probiotics, 958
Genitourinary infection, effect of probiotics (review), 958
Genome sequences, virulence gene searcher (research
note), 770
Genotyping
hepatitis B virus, patient with chronic HBV infection
(research note), 499
Legionella pneumophila, ﬂuorescent ampliﬁed length
polymorphism analysis, 704
MRSA, using oligonucleotide arrays, 825
Stenotrophomonas maltophilia, 880
Glycopeptide-intermediate Staphylococcus aureus (GISA)
Belgian hospitals, 214
incidence of hetero-intermediate strains in Maltese
hospitals (research note), 405
Gonococcal infections, Taiwan, 914
Gram-negative bacteria, use of term ’pan-drug-resistant’
(correspondence), 1049
Gram-positive bacteria
colistin treatment of ICU-acquired infections, 115
dalbavancin activity against, 95
Guillain—Barre´ syndrome, investigation of cytokine
induction in peripheral blood mononuclear cells by
heat-stable serotypes of Campylobacter jejuni
(research note), 63
HAART, structured intermittent interruption, chronic HIV
infection, 57
Haemodialysis, associated infections, 547
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Haemophilus inﬂuenzae
activity of 5 quinolones, 3 macrolides and telithromycin
against 12 different strains (research note), 1040
investigation of cap gene from CSF and blood of
meningitis patient, 637
sinusitis (research note), 407
type a, molecular characterisation, 637
type b, single-tube PCR assay in meningitis, 386
Hearing loss in brucellosis, investigation by audiometry,
559
Helicobacter pylori
pathogenicity (review), 602
cag pathogenicity island status (research note), 66
prevalence and risk factors in Benin, 611
susceptibility to clarithromycin, amoxycillin and
metronidazole, 307
Hepatitis A (HAV)
environmental risk factors, Bosnia and Herzegovina
(research note), 145
epidemiology, Bologna, and counselling and prophylaxis
in male homo/bisexuals (research note), 845
Hepatitis B (HBV)
association between tumour necrosis factor
gene polymorphisms and HBV infection,
52
Cuban women (research note), 764
genotyping of virus in patients with chronic infection
(research note), 499
Hepatitis C (HCV) (review), 86
Cuban women (research note), 764
Hernia repair, mesh-related infections (review), 3
Herpes simplex virus (HSV), type-2, Focus ELISA test
(correspondence), 423
Herpes viruses
disruption of DNA polymerases as antiviral strategy
(review), 437
interaction with human immunodeﬁciency virus within
oral mucosa (editorial), 83
High-performance liquid chromatography (HPLC),
monitoring of b-lactam plasma concentrations
during endocarditis treatment (research note), 76
Highly active anti-retroviral therapy see HAART
HIV (human immunodeﬁciency virus)
Cuban women (research note), 764
detection, comparison of TRI-DOT Rapid assay and
fourth-generation ELISA (research note), 850
interactions with Cryptococcus neoformans in AIDS-
associated cryptococcosis, 297
interactions with herpes viruses within oral mucosa
(editorial), 83
Mycobacterium bovis infections and (research note), 840
structured intermittent interruption treatment of chronic
infection, 57
Taiwan, 914
Honey, olive oil and beeswax in treatment of diaper
dermatitis (research note), 160
HPLC see High-performance liquid chromatography
HPV see Human papilloma virus
htrA gene, and LisRK two-component regulatory system
(editorial), 599
Human metapneumovirus (hMPV), respiratory tract
infections, 366
Human papilloma virus (HPV)
Cuban women (research note), 764
type 5, psoriasis and, 47
Hyperbaric oxygen as adjunctive treatment for
zygomycosis (editorial), 515
ica operon and bioﬁlm formation (review),
967
Imipenem
Acinetobacter baumannii pneumonia, efﬁcacy of imipenem
alone or with amikacin, 319
resistance
metallo-b-lactamase production in resistant Pseudomonas
aeruginosa, 73 (research note), 937 (correspondence)
risk factors for acquisition of resistant Acinetobacter
baumannii, 874
Immunity, effect of probiotics (review), 958
Immunocompromised patients, zygomycosis, hyperbaric
oxygen treatment (editorial), 515
Inﬂuenza infection, clinical and socio-economic impact on
children and their households (research note), 933
Inﬂuenza virus, comparison of enzyme immunoassays and
multiplex RT-PCR ELISA (research note), 848
Integrons
amikacin-resistant Escherichia coli (research note), 71
co-trimoxazole-resistant Gram-negative bacteria, 185
Intensive care units (ICUs)
assessment of soft tissue infections of extremities
(research note), 79
blood culture procedures for isolation of staphylococci in
paediatric unit (research note), 1035
colistin treatment of ICU-acquired infections caused by
multi-resistant Gram-negative bacteria, 115
continuous infusion b-lactams for pulmonary infections
(research note), 418
development of antibiotic-resistant Pseudomonas
aeruginosa, 887
genomic diversity of Staphylococcus epidermis isolates
(correspondence), 597
PER-1- and OXA-10-like b-lactamsases in
ceftazidime-resistant Pseudomonas aeruginosa
isolates, 193
pulmonary infections, continuous infusion b-lactams
(research note), 418
vancomycin-resistant Enterococcus faecalis (research note),
232
Joints, prostethic see Prosthetic joints
Kidney transplantation, cytomegalovirus infection in
recipients, 518
comparison of valacyclovir and ganciclovir prophylaxis,
736
Klebsiella pneumoniae
DHA-type b-lactamase (DHA-3) in, 893
extended-spectrum b-lactamase-producing,
625
FOX-5 b-lactamase-producing, activity of cefepime and
carbapenems against, 31
pathogenicity, 553
Lactobacillus plantarum, interference with Pseudomonas
aeruginosa in vitro and in infected burns, 472
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Legionella spp., role in acute respiratory infections (research
note), 410
Legionella pneumophila, genotyping using ﬂuorescent
ampliﬁed fragment length polymorphism analysis,
704
Legionnaire’s disease, surveillance in Austria (research
note), 413
Leishmaniasis, cutaneous, travellers (editorial), 343
Leptospirosis
clinical presentation, 391
lymphopenia and (correspondence), 857
Ligase chain reaction, Chlamydia trachomatis detection
(research note), 761
Lincosamide, correlation of agar dilution and VITEK2
system for detection of resistance, 656
Linezolid resistance in Germany 2001-2002, 39
Listeria monocytogenes
crossing of host barriers (review), 430
osmotolerance, LisRK two-component regulatory system
(editorial), 599
Listeriosis, invasive, Denmark, 618
Liver ﬂuke infection (editorial), 859
Lung abscess: diagnosis of Candida abscesses by
F-18-ﬂuorodeoxyglucose PET (research note), 493
Lung transplantation, Aspergillus infections after, 359
Lymphopenia, leptospirosis patients (correspondence), 857
Macrolides
activity against 12 Haemophilus inﬂuenzae strains with
different resistance phenotypes (research note),
1040
resistance
correlation of agar dilution and VITEK2 system for
detection of resistance, 656
prevalence of inducible clindamycin resistance in
macrolide-resistant staphylococci (research note),
337
resistance genes in association with integrase genes of
conjugative transposons, Streptococcus pneumoniae,
808
resistance mechanisms in Streptococcus pneumoniae, 312,
332 (research note)
Malaria: Now Malaria rapid diagnostic test, 901
Media: evaluation of three differential media for
presumptive identiﬁcation of yeasts (research note),
245, 513 (corrigendum)
Melioidosis: Burkholderia pseudomallei identiﬁcation in
blood culture supernatants (research note), 930
Meningitis
bacterial, diagnosis using single-tube multiplex PCR, 386
enterovirus, diagnosis by reverse transcription-PCR, 131
Meropenem susceptibility breakpoint for Pseudomonas
aeruginosa, 662
Mesh-related infections after hernia repair (review), 3
Metapneumovirus: human metapneumovirus respiratory
tract infections, 366
Methicillin-resistant Staphylococcus aureus (MRSA)
activity of medicinal plant extracts against hospital
isolates (research note), 510
community-acquired
Panton—Valentine leukocidin in (research note), 585
SCCmec types in, 447
inducible clindamycin resistance (research note), 582
Nepal (research note), 235
Panton—Valentine leukocidin (research note), 585
Poland, 379
with reduced glycopeptide susceptibility, Belgian
hospitals, 214
screening
cost-analysis of screening programmes, 466
on hospital admission, 457
use of broth enrichment and real-time PCR, 1027
typing
genotyping using oligonucleotide arrays, 825
PCR targeting SCCmec elements and orfX (research
note), 834
Methicillin-susceptible Staphylococcus aureus (MSSA),
Nepal (research note), 235
Metronidazole, susceptibility of Helicobacter pylori, 307
Microarrays, oligonucleotide
genotyping of MRSA, 825
Mycobacterium tuberculosis analysis, 531
MicroScan Walkway, susceptibility testing of
ﬂuoroquinolones and b-lactams (research note),
402
Moraxella catarrhalis, sinusitis (research note), 407
MRSA see Methicillin-resistant Staphylococcus aureus
Mucorales infections see Zygomycosis
Mycobacteria culture, external quality assessment, 1016
Mycobacterium bovis, pleuropulmonary infections (research
note), 840
Mycobacterium tuberculosis
detection using Cobas Amplicor system (research note),
593
drug-resistant, analysis using hybridisation on
oligonucleotide microarrays, 531
susceptibility testing
comparison of BACTEC TB-460 and ﬂow cytometric
analysis, 373
single-nucleotide polymorphism-based differentiation
and drug resistance detection by pyrosequencing,
122
Mycoplasma pneumoniae pneumonia, serum alanine
aminotransferase levels, 507(research note), 1051
(correspondence)
Myocarditis, Campylobacter infections (editorial), 253
Nappy rash, topical treatment with honey, olive oil and
beeswax (research note), 160
Necrotising fasciitis of extremities, patients admitted to
intensive care unit (research note), 79
Neisseria gonorrhoeae infections, Taiwan, 914
Neisseria meningitidis, single-tube PCR assay, 386
Neurosurgery, dynamics of serum procalcitonin following
(research note), 679
Nitric oxide (NO) production in alveolar epithelial cells,
effect of adenovirus E1A gene, 644
Nitric oxide synthase (NOS): effect of adenovirus E1A gene
on inducible and endothelial NOS in alveolar
epithelial cells, 644
Nocardiosis, clinical syndromes/susceptibility, Turkish
hospital (research note), 495
Nosocomial infections
Acinetobacter (review), 868
candidaemia in non-neutropenic patients in tertiary
hospital, 908
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carbapenem-resistant Acinetobacter baumannii, risk factors
and prognosis, 540
colistin treatment of ICU-acquired infections caused by
multi-resistant Gram-positive bacteria, 115
extended-spectrum b-lactamase-producing Escherichia
coli and Klebsiella pneumoniae, 625
imipenem-resistant Acinetobacter baumannii, risk factors,
874
mortality for bacterial infections according to antibiotic
susceptibility (research note), 502
MRSA screening programmes
cost analysis, 466
on hospital admission, 457
pan-drug-resistant Pseudomonas aeruginosa (research
note), 670
Stenotrophomonas maltophilia, 880
Streptococcus pneumoniae bloodstream infections, 919
therapeutic options for serious bacterial infections
(research note), 778
see also Intensive care units
Now Malaria rapid diagnostic test, 901
Olive oil, honey and beeswax in treatment of diaper
dermatitis (research note), 160
Oral mucosa, interactions between human
immunodeﬁciency virus and herpes viruses
(editorial), 83
Orthopaedic surgery, comparison of teicoplanin and
cephalosporins for anti-infective prophylaxis
(editorial), 775
Osmoregulation: LisRK two-component regulatory
system in listerial osmotolerance (editorial),
599
OXA-51 (novel class D carbapenemase) in Acinetobacter
baumannii, 15
Oxacillin resistance testing, staphylococci, evaluation of
Vitek 2 system (research note), 150
Oxygen, hyperbaric, as adjunctive treatment for
zygomycosis (editorial), 515
Panton—Valentine leukocidin (PVL) gene, community-
acquired MRSA, 447
PCR see Polymerase chain reaction
Penicillin resistance, decreasing rates of resistance in
Streptococcus pneumoniae, Taiwan (research note),
925
Pericarditis, Campylobacter infections (editorial), 253
Peritonitis
peritoneal dialysis-related, bacterial aetiology (research
note), 837
rapid identiﬁcation of Candida spp. by Raman
spectroscopy, 353
PET see Positron emission tomography
Plants, medicinal, activity against MRSA (research note),
510
Plasmodium falciparum infection, Now Malaria rapid
diagnostic test, 901
Pneumococcus see Streptococcus pneumoniae
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